Fulgent Genetics Retained Earnings (Accumulated Deficit) 2015-2025 | FLGT

Fulgent Genetics retained earnings (accumulated deficit) from 2015 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Fulgent Genetics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024 $590
2023 $633
2022 $801
2021 $658
2020 $151
2019 $-63
2018 $-63
2017 $-58
2016 $-55
2015 $-53
2014 $-10
Fulgent Genetics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2025-03-31 $579
2024-12-31 $590
2024-09-30 $596
2024-06-30 $611
2024-03-31 $620
2023-12-31 $633
2023-09-30 $761
2023-06-30 $774
2023-03-31 $786
2022-12-31 $801
2022-09-30 $825
2022-06-30 $823
2022-03-31 $812
2021-12-31 $658
2021-09-30 $553
2021-06-30 $431
2021-03-31 $351
2020-12-31 $151
2020-09-30 $-15
2020-06-30 $-62
2020-03-31 $-65
2019-12-31 $-63
2019-09-30 $-63
2019-06-30 $-65
2019-03-31 $-65
2018-12-31 $-63
2018-09-30 $-61
2018-06-30 $-60
2018-03-31 $-59
2017-12-31 $-58
2017-09-30 $-56
2017-06-30 $-55
2017-03-31 $-55
2016-12-31 $-55
2016-09-30 $-56
2016-06-30 $-55
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2014-12-31 $-10
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.646B $0.283B
Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.988B 53.85
Hims & Hers Health (HIMS) United States $13.954B 144.98
Tempus AI (TEM) United States $10.977B 0.00
IRhythm Technologies (IRTC) United States $4.526B 0.00
Inspire Medical Systems (INSP) United States $4.418B 69.02
Privia Health (PRVA) United States $3.048B 208.33
Enovis (ENOV) United States $2.027B 11.30
Clover Health Investments (CLOV) United States $1.832B 0.00
Schrodinger (SDGR) United States $1.721B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.305B 23.02
Azenta (AZTA) United States $1.242B 57.70
10x Genomics (TXG) United States $1.100B 0.00
Butterfly Network (BFLY) United States $0.574B 0.00
Talkspace (TALK) United States $0.504B 150.50
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.452B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.376B 834.00
Health Catalyst (HCAT) United States $0.271B 0.00
Nyxoah SA (NYXH) Belgium $0.231B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.134B 0.00
American Well (AMWL) United States $0.114B 0.00
MDxHealth SA (MDXH) Belgium $0.098B 0.00
CareCloud (CCLD) United States $0.088B 3.34
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.068B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.055B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
Movano (MOVE) United States $0.006B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00